Fingerprint
Dive into the research topics of 'Phase 1 dose-escalation study of CP-690 550 in stable renal allograft recipients: Preliminary findings of safety, tolerability, effects on lymphocyte subsets and pharmacokinetics'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically